Alphabet's $75B AI CapEx in 2025 fuels growth with 4X compute efficiency gains, driving ROI, market share, AI adoption, and ...

There goes the S&P's record close. The market benchmark dipped shortly after 10 a.m. and was hovering around breakeven. It's ...

A quartet of key stocks led by UnitedHealth Group dragged on the Dow to start the holiday-shortened week. The Dow was down 65 ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

Universal Images Group via Getty Images A loose tooth that won’t heal for no apparent reason, especially if it’s paired with pain or swelling, could signal more than a standard dental issue.

The Los Angeles Lakers began Luka Dončić's tenure with a win then followed it up with a loss on Wednesday, snapping a six-game winning streak and leaving them with some questions to answer.

A range-bound session marked trading at Pakistan Stock Exchange (PSX) on Thursday as investor sentiment remained mixed in the corporate earnings season. Though the KSE-100 index kicked off ...

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Trump Closed a Loophole for Low-Cost Imports ‒ Until All Hell Broke Loose By Laura Gottesdiener and Stephen Eisenhammer (Reuters) -Days after U.S. President Donald Trump ended duty-free entry ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...